sofosbuvir

Why Gilead's Sofosbuvir Is Better Than J&J's Simeprevir
Motley Fool
Tue, 10/29/13 - 09:21 am
Gilead
sofosbuvir
JNJ
hepatitis C
simeprevir
FDA panel backs Gilead Sciences' hepatitis C drug
Yahoo/AP
Sat, 10/26/13 - 08:07 am
Gilead
FDA
advisory panels
hepatitis C
sofosbuvir
The Most Important Week of the Year Has Arrived for Gilead Sciences
Motley Fool
Wed, 10/23/13 - 08:24 am
Gilead
sofosbuvir
hepatitis C
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Cleveland Clinic
JNJ
Pharmacyclics
Novartis
serelaxin
ibrutinib
sofosbuvir
Gilead
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
3 Companies Racing to Transform Hepatitis-C Treatment
Motley Fool
Thu, 09/19/13 - 02:58 am
hepatitis C
Gilead
sofosbuvir
AbbVie
Bristol-Myers Squibb
daclatasvir
asunaprevir
BMS-791325
Yes, Gilead Did It Again
Seeking Alpha
Sat, 08/31/13 - 10:29 am
Gilead
sofosbuvir
Gilead's sofosbuvir cures some of the toughest hepatitis C cases
Fierce Biotech
Wed, 08/28/13 - 12:38 pm
hepatitis C
Gilead
sofosbuvir
Four Promising Biotech Stocks With Upcoming Catalysts
Minyanville
Thu, 08/22/13 - 10:05 am
GSK
Sarepta
Gilead
sofosbuvir
SGX203
SGX942
Soligenix
drisapersen
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
Gilead's Potential Megablockbuster Raises the Bar
Motley Fool
Mon, 06/17/13 - 09:24 am
Gilead
sofosbuvir
hepatitis C
Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D
Seeking Alpha
Fri, 06/14/13 - 08:27 am
sofosbuvir
Atripla
Gilead
HIV
R&D
hepatitis C
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
Gilead Announces U.S. FDA Priority Review Designation for Sofosbuvir for the Treatment of Hepatitis C
Yahoo/BusinessWire
Sat, 06/8/13 - 10:10 am
Gilead Sciences
sofosbuvir
hepatitis C
hepatitis
Gilead's sofosbuvir gets EMA validation, now under assessment
The Fly on the Wall
Wed, 05/22/13 - 10:16 am
Gilead
Europe
sofosbuvir
hepatitis C
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Gilead's Hepatitis C Drug Sofosbuvir Offers Upside
Seeking Alpha
Thu, 05/9/13 - 09:40 am
hepatitis C
sofosbuvir
Gilead
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thu, 05/2/13 - 10:28 am
hepatitis C
Gilead
ledipasvir
sofosbuvir
Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg
Mon, 04/29/13 - 10:26 am
Gilead
Bristol-Myers Squibb
hepatitis C
declatasvir
sofosbuvir
Gilead-Bristol Hepatitis C Drug Combo Cures 100% in Study
Bloomberg
Sun, 04/28/13 - 12:04 pm
Gilead Sciences
Bristol-Myers Squibb
hepatitis C
hepatitis
sofosbuvir
daclatasvir

Pages